Almac Group Limited - Strategic SWOT Analysis Review

Almac Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Almac Group Limited (Almac) is a contract development and manufacturing organization provides a integrated services to pharmaceutical and biotechnology companies. The company offers a comprehensive range of services across the lifecycle of biopharmaceutical products which extend from research through pharmaceutical and clinical development to commercialization of products. Its services portfolio encompass diagnostics and biomarker development; clinical technologies; API (Active Pharmaceutical Ingriendient) services and chemical development; pharmaceutical development; analytical services; clinical services; and commercial services. The company operates through its subsidiaries in California, North Carolina and Pennsylvania in the US; Tokyo, Japan; and and Singapore.. Almac is headquartered in Craigavon, Northern Ireland, the UK.

Almac Group Limited Key Recent Developments

Mar 08, 2016: Almac Group Opens Companion Diagnostic Laboratory in Durham N.C.
Nov 09, 2015: Almac Group announces significant expansion in pharmaceutical development capacity
Jul 10, 2015: Almac Group Expands Asia Pacific Presence with New Regional Headquarters and Clinical Trial Supply Facility in Singapore
Apr 13, 2015: Almac Group Announce £3.5 Million Expansion of Peptide and Protein Technology Services
Jan 21, 2015: Almac Appoints VP Quality and Regulatory Affairs

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Frequently Asked Questions